DANIELLE GARTEN: Open Payments
NPI 1215576962 · WINSTON SALEM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$262 in 18 payments from 12 companies in 2025. Trend: 2023 $485 · 2024 $513 · 2025 $262
Food & beverage: $262
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $54 |
| SHIELD THERAPEUTICS INC | 2 | $38 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $36 |
| Biogen, Inc. | 1 | $20 |
| Hologic Sales and Service, LLC | 1 | $19 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $17 |
| PFIZER INC. | 1 | $17 |
| Exact Sciences Corporation | 1 | $15 |
| MILLICENT US INC | 1 | $14 |
Products named: Veozah, ACCRUFER, JOURNAVX, ZURZUVAE, APTIMA, Kyleena, GEMTESA, ABRYSVO.
Industry payments across NC — which companies pay providers there.
